These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 2132885)
1. Mumps incidence in Israel--impact of MMR vaccine. Slater PE; Roitman M; Costin C Public Health Rev; 1990-1991; 18(1):88-93. PubMed ID: 2132885 [TBL] [Abstract][Full Text] [Related]
2. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Bart KJ; Orenstein WA; Hinman AR Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117 [TBL] [Abstract][Full Text] [Related]
3. The control of mumps in Israel. Slater PE; Anis E; Leventhal A Eur J Epidemiol; 1999 Sep; 15(8):765-7. PubMed ID: 10555621 [TBL] [Abstract][Full Text] [Related]
4. Measles, mumps and rubella: control by vaccination. van Druten JA; de Boo T; Plantinga AD Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [TBL] [Abstract][Full Text] [Related]
5. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
6. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
7. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR; Choe YJ; Go UY; Kim YI; Lee JK Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654 [TBL] [Abstract][Full Text] [Related]
9. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases. Böttiger M; Christenson B; Strandell A; Romanus V Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776 [TBL] [Abstract][Full Text] [Related]
10. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369 [TBL] [Abstract][Full Text] [Related]
11. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft. Matter HC; Cloetta J; Zimmermann H J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669 [TBL] [Abstract][Full Text] [Related]
14. MMR vaccine: a new initiative. Miller C Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287 [No Abstract] [Full Text] [Related]
15. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
16. The measles-mumps-rubella vaccination program in Finland. Redd SC; Wharton M; Hadler SC; Orenstein WA N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540 [No Abstract] [Full Text] [Related]
17. The measles-mumps-rubella vaccination program in Finland. Lerman SJ N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541 [No Abstract] [Full Text] [Related]